FY2025 EPS Forecast for SBC Medical Group Lowered by Analyst

Key Points

• Zacks Small Cap has lowered its FY2025 EPS estimate for SBC Medical Group from $0.65 to $0.53, while the current consensus estimate remains at $5.02 per share.
• SBC Medical Group reported quarterly earnings of $0.02 per share, missing analysts' expectations of $0.14 and also falling short on revenue, which was $43.36 million compared to expected $44.71 million.
• Institutional investors have been active, with major purchases made by firms including Geode Capital Management LLC and SBI Securities Co. Ltd., resulting in a total of 60.82% of the stock now held by institutional investors.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Zacks Small Cap reduced their FY2025 earnings per share estimates for SBC Medical Group in a research note issued on Tuesday, August 19th. Zacks Small Cap analyst M. Marin now expects that the company will post earnings of $0.53 per share for the year, down from their prior estimate of $0.65. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last issued its quarterly earnings results on Wednesday, August 13th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.14 by ($0.12). SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. The business had revenue of $43.36 million for the quarter, compared to analysts' expectations of $44.71 million.

Separately, Wall Street Zen cut SBC Medical Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th.

SBC Medical Group Stock Up 1.4%

Shares of SBC stock traded up $0.06 on Wednesday, reaching $4.29. 43,474 shares of the company's stock traded hands, compared to its average volume of 44,726. SBC Medical Group has a 12-month low of $2.62 and a 12-month high of $19.50. The company has a debt-to-equity ratio of 0.03, a quick ratio of 3.95 and a current ratio of 3.98. The company has a market capitalization of $444.49 million, a P/E ratio of 13.41 and a beta of 1.27. The business's 50 day moving average price is $4.59 and its two-hundred day moving average price is $4.20.

Institutional Investors Weigh In On SBC Medical Group

Several institutional investors and hedge funds have recently made changes to their positions in the company. SBI Securities Co. Ltd. grew its position in SBC Medical Group by 227.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock worth $251,000 after acquiring an additional 37,623 shares during the last quarter. Geode Capital Management LLC acquired a new stake in SBC Medical Group during the 2nd quarter worth $455,000. XTX Topco Ltd bought a new position in SBC Medical Group during the 2nd quarter worth about $64,000. Finally, New York State Common Retirement Fund bought a new position in shares of SBC Medical Group in the 2nd quarter valued at about $104,000. Institutional investors and hedge funds own 60.82% of the company's stock.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.